“Detox” is one of the most misunderstood words in addiction medicine. Many people — and unfortunately some treatment programs — use it interchangeably with “treatment.” They are not the same. Understanding the difference matters, because the difference is a matter of evidence and outcomes.
Quick Answer
Detox (withdrawal management) manages the physical symptoms of opioid withdrawal. It does not treat opioid use disorder. Evidence consistently shows that detox alone — without ongoing MOUD or behavioral treatment — has high rates of return to use. MOUD (buprenorphine, methadone, naltrexone) addresses the neurobiological drivers of OUD over time, not just the acute withdrawal phase. [1, 2]
What Detox Is
Detoxification, or withdrawal management, refers to the medically supervised process of managing the physical symptoms of opioid withdrawal — sweating, vomiting, cramping, elevated heart rate, anxiety, and insomnia — while the body clears opioids.
Detox serves an important function: it manages physical safety and discomfort during the acute withdrawal phase. But it addresses only the immediate physical symptoms of opioid clearance — not the underlying neurobiological changes that drive opioid use disorder.
A successful detox means a person is no longer physically dependent at the acute level. It does not mean OUD is treated.
What MOUD Is
Medications for Opioid Use Disorder (MOUD) — buprenorphine, methadone, and naltrexone — are FDA-approved treatments that work on the opioid receptor system over time to:
- Reduce cravings driven by neurobiological changes that persist long after acute withdrawal
- Prevent the reinforcing effect of opioid use (by stabilizing receptors or blocking them)
- Normalize function so that the person can engage with work, relationships, and recovery
- Significantly reduce overdose risk, including the dangerous period when tolerance has dropped
MOUD does not simply manage symptoms. It treats the underlying disorder over a period of time sufficient for the brain to recalibrate. [1]
Side-by-Side Comparison
| Detox / Withdrawal Management |
MOUD (Buprenorphine, Methadone, Naltrexone) |
| Manages acute physical withdrawal symptoms |
Treats opioid use disorder over time |
| Duration: days to a few weeks |
Duration: months to years (individualized) |
| Does not address cravings after acute phase |
Specifically targets persistent cravings |
| Does not reduce long-term relapse risk significantly on its own |
Strongly reduces relapse and overdose risk [1, 2] |
| Can be an important first step |
Should follow or overlap with detox for most people with OUD |
| Can be performed in multiple settings (inpatient, outpatient) |
Office-based, telehealth (buprenorphine), OTP clinic (methadone), office-based (naltrexone) |
Why Detox Alone Has High Rates of Return to Use
This is not intuitive, but it is well-established in evidence: completing a detox program — even a high-quality, medically managed one — does not substantially change long-term OUD outcomes without ongoing treatment. Here is why:
- Cravings persist: The neurobiological changes that drive craving — particularly in dopamine and stress circuits — are not resolved by detox. They persist for months after acute withdrawal. See: What Happens in the Brain During Opioid Withdrawal.
- Tolerance drops rapidly: After detox, tolerance drops dramatically. A person who returns to use at their previous dose faces a high risk of fatal overdose. Detox, paradoxically, can increase overdose risk at the point of relapse.
- Triggers remain: Environmental, emotional, and social triggers that were associated with opioid use are still present. Without ongoing treatment and support, their power to drive relapse is substantial.
- Withdrawal is not treatment: Just as removing excess fluid from a failing heart does not cure heart failure, removing opioids from an opioid-dependent brain does not cure OUD. The underlying disorder requires ongoing treatment.
The period immediately after detox is a high-risk window for overdose. Tolerance drops rapidly during withdrawal. If relapse occurs at a previous dose, the risk of fatal overdose is significantly elevated. This is why transitioning from detox to ongoing MOUD or other evidence-based treatment is so important.
When Detox Is Valuable
Detox is not without value. It serves important roles:
- Ensuring physical safety during the acute withdrawal period — especially for polysubstance users or those with significant medical history
- Serving as a first step toward treatment — a bridge to MOUD or other ongoing care
- For naltrexone initiation — because naltrexone requires opioid-free status, a medically supervised detox can be the necessary precursor
- Providing a structured environment away from triggers and drug access during the most acute phase
The problem is not detox itself — the problem is when detox is presented or pursued as the complete treatment for OUD, rather than as a first step.
How to Think About a Treatment Plan
A comprehensive approach to OUD typically involves:
- Withdrawal management — managing the acute physical phase safely
- Medication for OUD — initiating buprenorphine, methadone, or naltrexone (with naltrexone requiring completed detox) as appropriate
- Behavioral support — individual counseling, group support, peer recovery support
- Ongoing engagement — regular clinical contact, dose monitoring, life-skill building
- Social and community support — housing stability, employment support, family connection
MOUD is most effective as part of this broader framework, not in isolation. SAMHSA refers to this as the “whole-patient approach.” [1]
Common Questions
If I completed detox successfully, do I still need MOUD?
For most people with OUD — particularly those with moderate-to-severe disorder — the evidence strongly favors initiating MOUD after or alongside detox. Whether MOUD is the right next step, and which medication, depends on individual factors. This is worth a direct conversation with your clinician.
What if I don't want to be on medication long-term?
Your preferences matter and should be part of the treatment conversation. Some people successfully complete naltrexone treatment and discontinue once stable. Others find they need longer-term medication support. There is no single correct path, and any clinician worth working with will take your goals seriously while also being honest about what the evidence shows.
My insurance covered detox but not MOUD. What can I do?
This is unfortunately common and a genuine barrier. Options include: appealing insurance decisions, seeking community health center or federally qualified health center care (which often provides sliding-scale MOUD), and contacting SAMHSA’s helpline (1-800-662-4357) for referral to programs that can help with cost.
Key Takeaways
- Detox manages the physical symptoms of acute withdrawal — it does not treat opioid use disorder.
- MOUD (buprenorphine, methadone, naltrexone) addresses the neurobiological drivers of OUD over time.
- Evidence consistently shows that detox alone has high rates of return to use without ongoing treatment.
- The period immediately after detox is a high-risk time for overdose due to dropped tolerance.
- Detox is most valuable as a first step, followed by MOUD or other ongoing evidence-based treatment.
- SAMHSA supports a whole-patient approach: medication, counseling, and social support.
Related Resources
Sources
- SAMHSA. Medications for Opioid Use Disorder: TIP 63. 2021. SAMHSA.gov
- Volkow ND, et al. Medication-assisted therapies — tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063-2066. PubMed
- CDC. Evidence-Based Strategies for Preventing Opioid Overdose. CDC.gov
This page provides general educational information. Treatment decisions should be made in consultation with a licensed healthcare provider.
